Spinal Surgery

Bleeding during spine surgery can significantly impair a surgeon’s visual field and lead to increased operating room time. Baxter's portfolio of haemostat, sealant and tissue repair products reduce bleeding and increase access by supporting surgical teams who improve patient mobility and quality of life.

Key Procedures

Each spine procedure provides unique challenges that can cause complications for the healing process. Here are a few examples.

Anterior Cervical Discectomy and Fusion (ACDF)

In ACDF surgeries, haemostats minimise blood loss and help to ease surgical complexities. FLOSEAL, Baxter's flowable haemostat, provides effective, quick haemostasis (90 seconds median time to haemostasis)1 to improve visibility and overall outcomes2.

Learn more about FLOSEAL >

Image of Inductigraft in applicator and logo

Posterolateral Spinal Fusion (PLF)

During this common spine procedure, surgical teams rely on haemostats and orthobiologics to manage blood loss and promote bone growth. INDUCTIGRAFT, Baxter's bioactive bone graft substitute, offers enhanced porosity and performance to achieve optimal fusion rates3,4,5*.

*Preclinical data. Results may not correlate to performance in humans

Learn more about INDUCTIGRAFT >

Ostene banner

Transforaminal Interbody Fusion (TLIF)

In another common spine surgery, Baxter's bone haemostasis material, OSTENE, provides immediate bone haemostasis. This water-soluble polymer does not require removal and dissolves within 48 hours. It can be used on all bleeding bone surfaces, including areas where bone fusion is critical6,7,8,9*.

*Preclinical data. Results may not correlate to performance in humans

Learn more about OSTENE >

Portfolio of Products


Prescribing Information:

Image removed. UK TISSEEL


Adverse Event and Product Complaint Handling

Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44) 01635 260360

Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 1604 704603).